 | Mohammad Afshar
Chief Executive Officer
Ariana Pharma |
 |
Rabia Ahmad
PET/SPECT Imaging Lead Scientist, Neurology
GE Healthcare LifeSciences
|
 |
Catherine Alix-Panabières
Director, Laboratory of Rare Human,Circulating Cells (LCCRH)
Cellular and Tissular Biopathology of Cancers Principal Investigator
University Medical Center of Montpellier
|
 |
Claudio Babiloni
Associate Professor of Physiology
The Department of Physiology and Pharmacology
University of Rome "La Sapienza" |
 |
Anne-Christine Bay-Jensen
Principal Scientist, Head of Rheumatology,
Nordic Bioscience, Biomarkers Research
|
 |
Christoph Borchers
Full Professor, University of Victoria;
Director, UVic Genome BC Proteomics Centre
|
 | Dirk Cerneus
Director Science
Clinical Pharmacology
Astellas Pharma |
 | Alessandra Cervino
Head of Biomarker Discovery
Enterome Bioscience |
 | Daniel Chelsky
Chief Scientific Officer
Caprion Biosciences |
 | Kevin Cox
Chief Executive Officer
Imanova |
 | Christian Dierks
Attorney and GP
Professor for Health Services Research
Charité Berlin, DIERKS + BOHLE Rechtsanwälte |
 | Axel Ducret
Project leader
Discovery Proteomics PS-TTB
Roche Pharma Research and Early Development F. Hoffmann-La Roche |
 | Anka Ehrhardt
Director Clinical Cytometry, Biomarker Technologies, ECTR
Bristol-Myers Squibb |
 | Joseph Ferrara
President
Boston Healthcare |
 | Geoffrey Hamilton-Fairley
Chief Executive Officer
Oncimmune |
 | Michael Heller
Professor, Nanoengineering & Bioengineering
University of California San Diego |
 | Ulrich Hoffmueller
Chief Business Officer and Founder
Epiontis GmbH |
 | Zhiyuan Hu
Professor
National Center for Nanoscience and Technology, China |
 | Shidong Jia
Scientist
Oncology Biomarker Development
Genentech |
 | Thomas Joos
Deputy Managing Director
NMI Natural and Medical Sciences Institute
University of Tuebingen |
 | Hans Lehrach
Professor, Vertebrate Genomics
Max Planck Institute for Molecular Genetics |
 | Jochen Lips
Market Development Manager
Adaptive Biotechnologies |
 | Phoebe Loh
Global Product Manager PreAnalytiX
Sample Technologies
QIAGEN GmbH |
 | Pierluigi Mauri
Chief of Proteomics & Metabolomics
Proteomics and Metabolomics Laboratory - CNR
Institute for Biomedical Tecnologies (ITB-CNR) |
